Cargando…
In which developing countries are patents on essential medicines being filed?
BACKGROUND: This article is based upon data gathered during a study conducted in partnership with the World Intellectual Property Organization on the patent status of products appearing on the World Health Organization’s 2013 Model List of Essential Medicines (MLEM). It is a statistical analysis aim...
Autores principales: | Beall, Reed F, Blanchet, Rosanne, Attaran, Amir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5485610/ https://www.ncbi.nlm.nih.gov/pubmed/28651631 http://dx.doi.org/10.1186/s12992-017-0262-4 |
Ejemplares similares
-
Is Patent “Evergreening” Restricting Access to Medicine/Device Combination Products?
por: Beall, Reed F., et al.
Publicado: (2016) -
Pan-Canadian overpricing of medicines: a 6-country study of cost control for generic medicines
por: Beall, Reed F, et al.
Publicado: (2014) -
Could patents interfere with the development of a cardiovascular polypill?
por: Beall, Reed F., et al.
Publicado: (2016) -
Upstream solutions for price-gouging on critical generic medicines
por: Houston, Adam R., et al.
Publicado: (2016) -
Comparative overview of innovation and patent filings in Radiopharmacy
por: Miranda, Ana Cláudia Camargo, et al.
Publicado: (2019)